Questo lavoro è stato finanziato dalla R &amp; D Systems, Inc.

1. Preparazione del campione <ol><li> Raccogliere lisati da non trattata, trattata ligando, o inibitore e le cellule trattate ligando seguendo le linee guida del umano fosfo-RTK datasheet array. Il tampone di lisi è stata ottimizzata per questo kit. La sostituzione dei tamponi di lisi altri possono influenzare le prestazioni finali della matrice. Per evitare la degradazione proteolitica campione, aggiungere 10 ug / ml di aprotinina, 10 pg / ml di leupeptina, e 10 ug / ml di pepstatina A al volume di tampone di lisi richiesti per ogni campione lisato di cellule fresche per ogni uso. </li><li> Lisato concentrazione deve essere misurata utilizzando un acido bicinconinico (BCA) dosaggio. Concentrazione del campione può essere empiricamente regolato per sensibilità ottimale e basso fondo. Una gamma di 100-300 mg di lisato è raccomandato come un punto di partenza iniziale. </li><li> Cicli gelo / disgelo di campioni deve essere evitato e la corretta conservazione dei lisati è necessaria per ottenere prestazioni ottimali. Scongelare i campioni congelati lisato su ghiaccio. </li></ol><ol><li> Portare tutti i componenti del kit a temperatura ambiente prima dell&#39;uso. Per evitare la contaminazione, indossare i guanti durante l&#39;esecuzione delle procedure. </li><li> Pipettare 2,0 ml di tampone Array 1 in ciascun pozzetto della 4-Well Multi-piatto da utilizzare. Buffer matrice 1 funge da buffer di blocco. </li><li> Utilizzo a testa piatta pinzette, rimuovere ogni membrana da utilizzare tra gli strati di protezione e collocare in un pozzo del 4-Well Multi-piatto. Il numero di serie deve essere rivolto verso l&#39;alto. </li><li> In caso di contatto con tampone Array 1, il colorante blu dalle macchie scompaiono, ma gli anticorpi di cattura vengono mantenuti nelle loro posizioni specifiche. </li><li> Incubare per 1 ora su una piattaforma oscillante. Orientare il vassoio in modo che ogni estremità matrice rocce per finire nel suo bene. La superficie della matrice deve essere completamente bagnata e coperta da buffer di blocco. </li><li> Mentre le membrane è bloccare, diluire la quantità desiderata di lisato cellulare per un volume finale di 1,5 ml con tampone Array 1. </li> &lt;li&gt; Buffer Array Aspirare 1 da pozzi della 4-Well Multi-piatto e aggiungere soluzioni diluite lisato. Mettere il coperchio sul 4-Well Multi-piatto. </li><li> Incubare per una notte a 2-8 ° C su una piattaforma oscillante. Un tempo di incubazione più breve può essere utilizzata se la sensibilità ottimale non è necessaria. </li><li> Rimuovere con cura ogni membrana dal 4-Well Multi-piatto e il luogo in singoli contenitori di plastica con 20 ml di tampone di lavaggio 1X. L&#39;hotel a 4-Well Multi-piatto non può essere utilizzato per completare le fasi di lavaggio. Sciacquare la 4-Well Multi-piatto con acqua deionizzata o distillata e asciugare accuratamente. </li><li> Lavare ogni membrana con tampone di lavaggio 1X per 10 min su una piattaforma oscillante shaker. Ripetere due volte per un totale di 3 lavaggi. </li><li> Diluire l&#39;anti-fosfo-tirosina-perossidasi di rafano (HRP) rilevamento buffer in 1X tampone Array 2 utilizzando il fattore di diluizione sull&#39;etichetta del flacone. Pipettare 2,0 ml di soluzione diluita in ciascun pozzetto della 4-Well Multi-piatto. </li><li> Rimuovere con cura ogni membrana dal suo contenitore di lavaggio.Permettono tampone in eccesso dalla membrana e la membrana ritorna al 4-Well Multi-piatto contenente il diluita anti-fosfo-tirosina-HRP. Coprire i pozzetti con il coperchio. </li><li> Incubare per 2 ore a temperatura ambiente su una piattaforma oscillante. </li><li> Lavare ogni matrice come descritto in precedenza. </li><li> Completare i passaggi rimanenti senza interruzione. Rimuovere con cura ogni membrana dal suo contenitore di lavaggio. Lasciare tampone in eccesso dalla membrana tamponando il bordo inferiore su carta assorbente. Posizionare ogni membrana su un protettore foglio di plastica con il numero di identificazione rivolto verso l&#39;alto. </li><li> Pipettare 1 ml del reagente preparato Chemi Mescolare in modo uniforme su ogni membrana. Utilizzando meno di 1 ml di miscela di reagente Chemi per membrana può causare una copertura incompleta della membrana. Sostituzione di alcuni reagenti ad alta intensità per reagenti chemiluminescenti Chemi 1 e 2 possono provocare sia sfondo aumentata o diminuita a seconda del segnale del reagente. </li><li> Coprire accuratamente con una plasticafoglio di protezione. Delicatamente appianare eventuali bolle d&#39;aria e garantire Mix reagente Chemi si diffonde in modo uniforme in tutti gli angoli di ogni membrana. Incubare per 1 min. </li><li> Asciugamani di carta di posizione sulla parte superiore e sui lati della protezione foglio di plastica che contiene le membrane e con attenzione spremere eccesso Mix Reagente Chemi. </li><li> Rimuovere la protezione superiore foglio di plastica e adagiare un laboratorio assorbente imbevuto di sopra delle membrane per cancellare l&#39;eventuale restante miscela di reagente Chemi. </li><li> Lasciando membrane sul foglio di plastica di protezione basso, coprire le membrane con la pellicola trasparente avendo cura di lisciare delicatamente eventuali bolle d&#39;aria. Avvolgere la pellicola di plastica in eccesso intorno alla parte posteriore del foglio di protezione in modo che le membrane e protettore foglio vengono completamente avvolta. </li><li> Posizionare le membrane con i numeri di identificazione rivolti verso l&#39;alto, in un rullino autoradiografia che non viene utilizzato con rilevamento isotopo radioattivo. </li><li> Esporre su pellicola Kodak Luce BioMax per 1-10 min. Esposizioni multiple sono raccomfinita. In alternativa, le immagini possono essere raccolti utilizzando un sensore compatibile chemiluminescenza come la Carestream Health Immagine Stazione 4000MM PRO. </li></ol> 3. Analisi dei dati <ol><li> Segnali positivi osservati sulla pellicola sviluppata possa individuare rapidamente ponendo la sovrapposizione trasparenza sull&#39;immagine matrice e allineandolo con le coppie di punti di riferimento stampati negli angoli per questo scopo. Il numero di identificazione stampato sulla matrice deve essere posizionato sul lato sinistro aveva. La posizione dei controlli e anticorpi di cattura sono elencati in appendice della Human fosfo-RTK datasheet array. </li><li> Densità di pixel su pellicola sviluppata possono essere raccolti con una trasmissione in modalità scanner, come la Epson Perfection V750 PRO. </li><li> Creare un modello per analizzare la densità di pixel in ogni punto della matrice utilizzando un apposito programma di analisi software di imaging. Programmi compatibili includono software ImageQuant o ArrayVision da GE, sof Vision occidentaletware con modelli specifici per proteoma Array Profiler, BioRad Quantity One, Adobe Photoshop, NIH ImageJ e AlphaView proteina semplice. </li><li> Esporta i valori del segnale in un file di foglio di calcolo per la manipolazione in un programma come Microsoft Excel. </li><li> Determinare il segnale medio (densità di pixel) della coppia di punti duplicati rappresentano ogni RTK. </li><li> Sottrarre un segnale mediato sfondo da ogni macchia. Utilizzare un segnale proveniente da una zona libera della matrice o macchie di controllo negativo come valore di fondo. </li><li> Confrontare i segnali corrispondenti matrici differenti per determinare la variazione relativa in livelli di fosforilazione RTK tra campioni. </li></ol> 4. Risultati rappresentativi Questo protocollo dimostra come l&#39;umano Phospho-RTK matrice può essere usata per selezionare gli effetti della stimolazione ligando e inibitori sulla fosforilazione RTK. In figura 1, dato viene mostrato per MDA-MB-453 cellule che erano non trattata, trattata con 100 ng/ Ml rhNRG-β1/HRG-β1 (HRG-β1) per 5 min, o pre-trattati con inibitori noti della famiglia ErbB 8-11 prima HRGβ1 trattamento. Per gli esperimenti di inibitori, le cellule sono state incubate con 1 pM HDS 029, 200 nM PD 153.035, o 200 nM PD 158.780 in SFM per tre ore. Ogni matrice è stata incubata con 100 microgrammi di lisato. Un aumento di fosforilazione è osservato per ErbB2, ErbB3 e ERBB4 macchie di cattura quando si confrontano le cellule non trattate con HRG-β1 trattati MDA-MB-453 cellule. Il trattamento delle cellule con tutti e tre gli inibitori selettivi della famiglia ErbB prima HRG-β1 incubazione causato riduzioni ErbB2, ERBB3 e ErbB4 fosforilazione. In figura 2, dato viene mostrato per cellule Kato III noti per sovraesprimere R2 RTK FGF. In questa serie di esperimenti, Kato III erano cellule non trattate, trattate con 100 ng / ml rhFGF acido (FGF) e 1 mg / ml di eparina, o pretrattati con FGF R inibitori selettivi 12-15 prima del trattamento conFGF ed eparina. Il PD173074 inibitori, PD 161.570, 166.285 e PD sono stati usati ad una concentrazione di 1 pM e incubati con le cellule Kato III per 3 ore in siero media liberi. Mentre non vi è fosforilazione costitutiva sia R EGF e FGF R2 in cellule non trattate KATO III, un aumento fosforilazione R2 FGF è stato osservato dopo trattamento FGF. Incubazione delle cellule con PD 173074, PD 161570, 166285 o PD ha determinato una riduzione FGF R2 e EGF fosforilazione R. Sebbene questi inibitori sono noti influenzare la fosforilazione dei membri della famiglia FGF R, questi risultati dimostrano l&#39;utilità della Human Phospho-RTK matrice per monitorare l&#39;effetto di una specifica concentrazione di inibitore può avere su RTKs altri, come EGF R in questo caso. <img alt="Figura 1" fo:content-width="4.5in" fo:src="/files/ftp_upload/4199/4199fig1highres.jpg" src="/files/ftp_upload/4199/4199fig1.jpg" /> Figura 1. Induzione e inibizione della ricezionetor fosforilazione della tirosina chinasi in cellule di cancro al seno. immagini Array di proteoma Profiler umani fosfo-RTK array e dei profili corrispondenti istogrammi vengono visualizzati. MDA-MB-453 cellule erano trattati o trattati con inibitori RTK seguita da trattamento con NRG-β1/HRG-β1. L&#39;array è stato utilizzato per monitorare gli effetti degli inibitori di chinasi fosforilazione in MDA-MB-453 cellule. <a href="http://www.jove.com/files/ftp_upload/4199/4199fig1large.jpg" target="_blank">Clicca qui per ingrandire la figura</a> . <img alt="Figura 2" fo:content-width="4.5in" fo:src="/files/ftp_upload/4199/4199fig2highres.jpg" src="/files/ftp_upload/4199/4199fig2.jpg" /> Figura 2. Immagini Array induzione e inibizione della fosforilazione recettore tirosin-chinasi in cellule di cancro gastrico. Da un proteoma umano Profiler fosfo-RTK array e dei profili corrispondenti istogrammi vengono visualizzati. Kato cellule III sono state untreated o trattati con inibitori RTK seguito da trattamento con acido FGF ed eparina. <a href="http://www.jove.com/files/ftp_upload/4199/4199fig2large.jpg" target="_blank">Clicca qui per ingrandire la figura</a> . Riferimenti <ol><li> Henriksson, ML, Edin, S., Dahlin, AM, Oldenborg, PA, Oberg, A., Van Guelpen, B., Rutegard, J., Stenling, R., &amp; Palmqvist, R. cellule tumorali del colon-retto attivare fibroblasti adiacenti risultanti in FGF1/FGFR3 segnalazione e invasione maggiore. Am. J. Pathol. 178, 1387-1394 (2011). </li><li> Morishita, A., Gong, J., Nomura, T., Yoshida, H., Izuishi, K., Suzuki, Y., Kushida, Y., Haba, R., D&#39;Armiento, J., &amp; Masaki, T. L&#39;uso della matrice per identificare proteine ​​chinasi del recettore tirosin targeting per il trattamento del cancro del colon umano. Int. J. Oncol. 37, 829-835 (2010). </li><li> Agaram, NP, Laquaglia, MP, Ustun, B., Guo, T., Wong, GC, Socci, ND, Maki, RG,DeMatteo, RP, Besmer, P., &amp; Antonescu, CR Caratterizzazione molecolare dei tumori gastrointestinali stromali pediatrici. Clin. Cancer Res. 14, 3204-3215. (2008). </li><li> Stommel, JM, Kimmelman, AC, Ying, H., Nabioullin, R., Ponugoti, AH, Wiedemeyer, R., Stegh, AH, Bradner, JE, Ligon, KL, Brennan, C., Chin, L., &amp; DePinho, coattivazione RA di tirosin-chinasi del recettore agisce sulla reazione delle cellule tumorali di terapie mirate. Scienza. 318, 287-290 (2007). </li><li> Agarwal, S., Zerillo, C., Kolmakova, J., Christensen, JG, Harris, LN, Rimm, DL, DiGiovanna, MP, e Stern, DF Associazione costitutivamente attiva del recettore del fattore di crescita degli epatociti (Met), con resistenza ad un doppio inibitore EGFR/Her2 in cellule polmonari non a piccole cellule di cancro. fr. J. Cancer. 100, 941-949 (2009). </li><li> Dewaele, BM, Floris, G., Finalet-Ferreiro, J., Fletcher, CD, Coindre, JM, Guillou, L., Hogendoorn, PC, Wozniak, A., Vanspauwen, V., Schoffski, P., MARYNEN, P., Vandenbergh, P., Sciot, R., &amp; Debiec-Rychter, M. Co-attivato e PDGFRA EGFR sono potenziali bersagli terapeutici nel sarcoma intimale. Cancer Res.. 70, 7304-7314 (2010). </li><li> Yoon, YK, Kim, HP, Han, SW, Hur, HS, Oh, DY, Im, SA, Bang, YJ, &amp; Kim, combinazione TY di EGFR e MEK1 / 2 inibitore mostra effetti sinergici di EGFR/HER3-dependent sopprimendo attivazione di AKT in cellule umane di cancro gastrico. Mol. Cancer Ther. 8, 2526-2536 (2009). </li><li> Fry, DW, Nelson, JM, Slintak, V., Keller, PR, Rewcastle, GW, Denny, WA, Zhou, H., e ponti, le proprietà AJ biochimici e antiproliferativa di 4 - [AR (alcalino) ilammino] pyridopyrimidines, una nuova classe chimica del potente e specifico inibitore del fattore di crescita epidermico recettore tirosina chinasi. Biochem. Pharmacol. 54, 877-887 (1997). </li><li> Bos,M., Mendelsohn, J., Kim, YM, Albanell, J., Fry, DW, e Baselga, J. PD153035, un inibitore della tirosin-chinasi, impedisce l&#39;attivazione del fattore di crescita epidermico recettore ed inibisce la crescita delle cellule tumorali in un recettore numero- modo dipendente. Clin. Cancer Res.. 3, 2099-2106 (1997). </li><li> Stoll, SW, Kansra, S., Peshick, S., Fry, DW, Leopold, WR, Wiesen, JF, Sibilia, M., Zhang, T., Werb, Z., Derynck, R., Wagner, EF, e l&#39;anziano, l&#39;utilizzo differenziale JT e la localizzazione di tirosina chinasi del recettore ErbB in pelle rispetto ai cheratinociti normali e maligni. Neoplasia. 3, 339-350 (2001). </li><li> Klutchko, SR, Zhou, H., Winters, RT, Tran, TP, Ponti, AJ, Althau, IW, Amato, DM, Elliott, WL, Meade, MA, Roberts, BJ, Fry, DW, Gonzales, AJ, Harvey , PJ, Nelson, JM, Sherwood, V., Han, HK, Pace, G., smaill, JB, Denny, WA, e Showalter, HD inibitori della tirosina chinasi. 19. 6-alknyamides di 4-anilinoquinazolines e anilinopyrido 4-[3,4-d] pirimidine come inibitori irreversibili della famiglia ErbB di recettori tirosina chinasi. J. Med. Chem. 49, 1475-1485 (2006). </li><li> Kunii, K., Davis, L., Gorenstein, J., Hatch, H., Yashiro, M., Di Bacco, A., Elbi, C., &amp; Lutterbach, B. FGFR2-amplificati gastrico linee di cellule tumorali richiedono FGFR2 e ERBB3 segnalazione per la crescita e la sopravvivenza. Cancer Res.. 68, 2340-2348 (2008). </li><li> Zhou, W., Hur, W. McDermott, U., Dutt, A., Xian, W., Ficarro, SB, Zhang, J., Sharma, SV, Brugge, J., Meyerson, M., Settleman, J . &amp; Gray, NS Un approccio struttura-guida per la creazione di inibitori FGFR covalenti. Chem. Biol. 17, 285-295 (2010). </li><li> Batley, BL, Doherty, AM, Hamby, JM, Lu, GH, Keller, P., Dahring, TK, Hwang, O., Crickard, K., &amp; Panek inibizione RL di FGF-1 attività recettore tirosin-chinasi di PD 161570 , una nuova proteina-Inibitori della tirosin chinasi. Life Sci. 62. 143-150 (1998). </li><li> Panek, RL, Lu GH, Klutchko, SR, Batley, BL, Darhing, TK, Hamby, JM, Hallak, H., Doherty, AM, &amp; Keiser, JA Caratterizzazione in vitro farmacologica di PD 166285, un potente nuovo nanomolare e ampiamente attiva della proteina tirosina chinasi. J. Pharmacol. Esp. Ther. 283, 1433-1444 (1997). </li></ol>

The Human fosfo-RTK è un&#39;alternativa economica e veloce per i metodi tradizionali come immunoprecipitazione (IP) Western per i cambiamenti di screening nella fosforilazione RTK. Usando questo metodo, i livelli relativi di 42 fosfo-RTKs stati selezionati simultaneamente utilizzando un unico campione di MDA-MB-453 o lisato cellulare Kato III. Inoltre, questo saggio matrice richiesta 2,5 hr di mani-in tempo, rendendo questo metodo molto più tempo efficace di eseguire più IP-western. Con l&#39;ausilio di un metodo di rilevazione di chemiluminescenza, senza attrezzature specializzate al di là di ciò che viene in genere utilizzato per raccogliere i dati è stato richiesto occidentali. Array sono sensibili e possono essere utilizzati per confrontare i cambiamenti nella fosforilazione causate dai ligando e trattamento inibitore. Questo metodo consente anche la valutazione della selettività inibitore di off-target RTKs. Risultati positivi possono essere ulteriormente valutata usando un saggio quantitativo come un ELISA. Per utilizzare in modo efficace gli array per controllare i cambiamentinella fosforilazione, alcune linee guida fondamentali sperimentali devono essere seguite. In primo luogo, gli esperimenti devono includere campioni di controllo appropriate. Ad esempio, in questi esperimenti l&#39;effetto degli inibitori di MDA-MB-453 o Kato III lisati sono stati misurati su campioni lisati preparati nello stesso giorno. Dati di matrice solo che vengono raccolti entro lo stesso esperimento devono essere analizzate per minimizzare le variazioni di segnale dovute a differenze di manipolazione dei campioni, il tempo di incubazione, tecnica pipetta, o tecnica di lavaggio. Intensità di segnale confronto tra due analiti sulla membrana stessa non è raccomandato, in quanto gli anticorpi di cattura non sono stati selezionati per avere affinità parallele.

<table border="1">
	<tbody>
		<tr>
			<td>Name of the reagent</td>
			<td>Company</td>
			<td>Catalogue number</td>
			<td>Comments (optional)</td>
		</tr>
		<tr>
			<td><a href="http://www.rndsystems.com/product_results.aspx?k=ary001" target="_blank">Human Phospho-RTK Array Kit</a></td>
			<td>R&amp;D Sytems</td>
			<td>ARY001</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Aprotinin</td>
			<td>Sigma</td>
			<td>A6279</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Leupeptin</td>
			<td>Tocris</td>
			<td>1167</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Pepstatin A</td>
			<td>Tocris</td>
			<td>1190</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>MDA-MB-453 cells</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Kato III cells</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td><a href="http://www.rndsystems.com/product_results.aspx?k=396-hb" target="_blank">Recombinant Human NRG1-beta 1/HRG1-beta 1 EGF Domain</a></td>
			<td>R&amp;D Systems</td>
			<td>396-HB-050</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td><a href="http://www.rndsystems.com/product_results.aspx?k=232-fa" target="_blank">Recombinant Human FGF acidic (aa 16-155)</a></td>
			<td>R&amp;D Systems</td>
			<td>232-FA-025</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Heparin</td>
			<td>Sigma</td>
			<td>H4784</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>HDS 029</td>
			<td>Tocris</td>
			<td>2646</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>PD 153035</td>
			<td>Tocris</td>
			<td>1037</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>PD 158780</td>
			<td>Tocris</td>
			<td>2615</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>PD 173074</td>
			<td>Tocris</td>
			<td>3044</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>PD 161570</td>
			<td>Tocris</td>
			<td>3724</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>PD 166285</td>
			<td>Tocris</td>
			<td>3785</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>BCA assay</td>
			<td>Pierce</td>
			<td>23225</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Phosphate-Buffer Saline (PBS)</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Pipettes and pipette tips</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Gloves</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Deionized or distilled water</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Flat-tipped tweezers</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Rocking platform shaker</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Microcentrifuge</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Plastic containers with the capacity to hold 50 ml</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
			<td>For washing arrays</td>
		</tr>
		<tr>
			<td>Plastic transparent sheet protector</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Plastic wrap</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Absorbent lab wipes</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Paper towels</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Autoradiography cassette</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Film developer</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Kodak BioMax Light Film</td>
			<td>Carestream Health</td>
			<td>178 8207</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Film developer</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Image Station 4000MM PRO</td>
			<td>Carestream Health</td>
			<td>&nbsp;</td>
			<td>Chemiluminescence imager compatible with collection of western data may be used instead of film and a film developer.</td>
		</tr>
		<tr>
			<td>Epson Perfection Scanner</td>
			<td>Epson</td>
			<td>V750 PRO</td>
			<td>Flatbed scanner with transparency adaptor capable of transmission mode</td>
		</tr>
		<tr>
			<td>Image Analysis Software</td>
			<td>GE,WesternVision, BioRad, Adobe, NIH, Protein Simple, etc</td>
			<td>&nbsp;</td>
			<td>ImageQuant, ArrayVision, Western Vision, Quantity One, Photoshop, ImageJ, AlphaView, or other compatible program</td>
		</tr>
		<tr>
			<td>Microsoft Excel</td>
			<td>Microsoft</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Computer capable of running image analysis software and Microsoft Excel.</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
	</tbody>
</table>

profiling changes in receptor tyrosine kinase phosphorylation using antibody arrays - advertisement

La disregolazione di recettore tirosina chinasi (RTK), l&#39;espressione e la fosforilazione è frequentemente associata alla diffusione di sviluppo e metastatica delle cellule tumorali. 1-3 notevole impegno si è concentrato sugli inibitori in via di sviluppo per indirizzare specifiche RTK e interrompere le vie di segnalazione aberranti associate a stati di malattia . 4-7 La scopo di questo studio è stato quello di misurare gli effetti di un numero selezionato di inibitori sulla fosforilazione RTK. Questo studio ha utilizzato l&#39;Umano fosfo-RTK array, che è un immunodosaggio su membrana a sandwich per monitorare aumenti o diminuzioni nella fosforilazione di RTK numerosi simultaneamente in un singolo campione. In questo saggio, sia RTK fosforilata e non fosforilata presenti in un campione lisato sono catturati da anticorpi discreti stampati in duplicato su una membrana di nitrocellulosa delle dimensioni di un vetrino da microscopio. Dopo il lavaggio, gli array sono incubati con anti-fosfo-tirosina-perossidasi di rafano (HRP),che panini con RTK fosforilata catturati sulla matrice. A seguito di una seconda fase di lavaggio, gli array sono incubati con reagenti chemiluminescenti. Segnale generato ad ogni punto di matrice è proporzionale alla quantità di fosfo-proteina legata per ciascun anticorpo di cattura. In questi esperimenti, gli array sono stati utilizzati per misurare aumenti fosforilazione dopo stimolazione del ligando o MDA-MB-453 cancro al seno o KATO III cellule di carcinoma gastrico, nonché per caratterizzare diminuzione fosforilazione legati al trattamento delle cellule con inibitori selettivi verso ErbB o FGF R familiari.

Proteoma array di anticorpi Profiler sono un modo conveniente ed efficiente per controllare i cambiamenti delle recettore tirosin-chinasi (RTK) fosforilazione senza eseguire numerosi immunoprecipitazione (IP) Western. La matrice ARY001 RTK umana consente la misura qualitativa di RTK multipli in un singolo campione mediante chemiluminescenza.

Modifiche profiling in fosforilazione recettore tirosina chinasi utilizzando Array Anticorpo - Pubblicità

The dysregulation of receptor tyrosine kinase (RTK) expression and phosphorylation is frequently associated with the development and metastatic spread of ...

profiling-changes-receptor-tyrosine-kinase-phosphorylation-using

Without Section

Profiling Changes in Receptor Tyrosine Kinase Phosphorylation using Antibody Arrays - ADVERTISEMENT

11.6K Views.  R&D Systems, Inc.. Proteoma array di anticorpi Profiler sono un modo conveniente ed efficiente per controllare i cambiamenti delle recettore tirosin-chinasi (RTK) fosforilazione senza eseguire numerosi immunoprecipitazione (IP) Western. La matrice ARY001 RTK umana consente la misura qualitativa di RTK multipli in un singolo campione mediante chemiluminescenza.

Video: Modifiche profiling in fosforilazione recettore tirosina chinasi utilizzando Array Anticorpo - Pubblicità

Monitoring Protein Adsorption with Solid-state Nanopores

Solid-state nanopores have been used to perform measurements at the single-molecule level to examine the local structure and flexibility of nucleic acids 1-6, the unfolding of proteins 7, and binding affinity of different ligands 8. By coupling these nanopores to the resistive-pulse technique 9-12, such measurements can be done under a wide variety of conditions and without the need for labeling 3. In the resistive-pulse technique, an ionic salt solution is introduced on both sides of the nanopore. Therefore, ions are driven from one side of the chamber to the other by an applied transmembrane potential, resulting in a steady current. The partitioning of an analyte into the nanopore causes a well-defined deflection in this current, which can be analyzed to extract single-molecule information. Using this technique, the adsorption of single proteins to the nanopore walls can be monitored under a wide range of conditions 13. Protein adsorption is growing in importance, because as microfluidic devices shrink in size, the interaction of these systems with single proteins becomes a concern. This protocol describes a rapid assay for protein binding to nitride films, which can readily be extended to other thin films amenable to nanopore drilling, or to functionalized nitride surfaces. A variety of proteins may be explored under a wide range of solutions and denaturing conditions. Additionally, this protocol may be used to explore more basic problems using nanopore spectroscopy.

A method of using solid-state nanopores to monitor the non-specific adsorption of proteins onto an inorganic surface is described. The method employs the resistive-pulse principle, allowing for the adsorption to be probed in real-time and at the single-molecule level. Because the process of single protein adsorption is far from equilibrium, we propose the employment of parallel arrays of synthetic nanopores, enabling for the quantitative determination of the apparent first-order reaction rate constant of protein adsorption as well as and the Langmuir adsorption constant.

Monitoraggio delle proteine ​​con a stato solido Nanopori

Solid-state nanopores have been used to perform measurements at the single-molecule level to examine the local structure and flexibility of nucleic acids ...

Ricerca

JoVE Journal

Bioingegneria

Determining the Phagocytic Activity of Clinical Antibody Samples

Antibody-driven phagocytosis is induced via the engagement of Fc receptors on professional phagocytes, and can contribute to both clearance as well as pathology of disease. While the properties of the variable domains of antibodies have long been considered critical to in vivo function, the ability of antibodies to recruit innate immune cells via their Fc domains has become increasingly appreciated as a major factor in their efficacy, both in the setting of recombinant monoclonal antibody therapy, as well as in the course of natural infection or vaccination1-3.
Importantly, despite its nomenclature as a constant domain, the antibody Fc domain does not have constant function, and is strongly modulated by IgG subclass (IgG1-4) and glycosylation at Asparagine 2974-6. Thus, this method to study functional differences of antigen-specific antibodies in clinical samples will facilitate correlation of the phagocytic potential of antibodies to disease state, susceptibility to infection, progression, or clinical outcome.
Furthermore, this effector function is particularly important in light of the documented ability of antibodies to enhance infection by providing pathogens access into host cells via Fc receptor-driven phagocytosis7. Additionally, there is some evidence that phagocytic uptake of immune complexes can impact the Th1/Th2 polarization of the immune response8.
Here, we describe an assay designed to detect differences in antibody-induced phagocytosis, which may be caused by differential IgG subclass, glycan structure at Asn297, as well as the ability to form immune complexes of antigen-specific antibodies in a high-throughput fashion. To this end, 1 &mu;m fluorescent beads are coated with antigen, then incubated with clinical antibody samples, generating fluorescent antigen specific immune complexes. These antibody-opsonized beads are then incubated with a monocytic cell line expressing multiple Fc&gamma;Rs, including both inhibitory and activating. Assay output can include phagocytic activity, cytokine secretion, and patterns of Fc&gamma;Rs usage, and are determined in a standardized manner, making this a highly useful system for parsing differences in this antibody-dependent effector function in both infection and vaccine-mediated protection9.

We present a high-throughput flow cytometric assay to determine the phagocytic activity of antigen-specific antibodies from clinical samples, utilizing fluorescent antigen-coated beads and a monocytic cell line expressing multiple Fc receptors&#x2014;providing receptor usage and phagocytic activity determinations in a standardized and reproducible fashion for any antigen of interest.

Determinazione dell&#39;attività fagocitaria dei Campioni anticorpi clinici

Antibody-driven phagocytosis is induced via the engagement of Fc receptors on professional phagocytes, and can contribute to both clearance as well as ...

Immunologia e infezioni

Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells

Cancer immunotherapy can harness the specificity of immune response to target and eliminate tumors. Adoptive cell therapy (ACT) based on the adoptive transfer of T cells genetically modified to express a chimeric antigen receptor (CAR) has shown considerable promise in clinical trials1-4. There are several advantages to using CAR+ T cells for the treatment of cancers including the ability to target non-MHC restricted antigens and to functionalize the T cells for optimal survival, homing and persistence within the host; and finally to induce apoptosis of CAR+ T cells in the event of host toxicity5.
Delineating the optimal functions of CAR+ T cells associated with clinical benefit is essential for designing the next generation of clinical trials. Recent advances in live animal imaging like multiphoton microscopy have revolutionized the study of immune cell function in vivo6,7. While these studies have advanced our understanding of T-cell functions in vivo, T-cell based ACT in clinical trials requires the need to link molecular and functional features of T-cell preparations pre-infusion with clinical efficacy post-infusion, by utilizing in vitro assays monitoring T-cell functions like, cytotoxicity and cytokine secretion. Standard flow-cytometry based assays have been developed that determine the overall functioning of populations of T cells at the single-cell level but these are not suitable for monitoring conjugate formation and lifetimes or the ability of the same cell to kill multiple targets8.
Microfabricated arrays designed in biocompatible polymers like polydimethylsiloxane (PDMS) are a particularly attractive method to spatially confine effectors and targets in small volumes9. In combination with automated time-lapse fluorescence microscopy, thousands of effector-target interactions can be monitored simultaneously by imaging individual wells of a nanowell array. We present here a high-throughput methodology for monitoring T-cell mediated cytotoxicity at the single-cell level that can be broadly applied to studying the cytolytic functionality of T cells.

We describe a single-cell high-throughput assay to measure cytotoxicity of T cells when incubated with tumor target cells. This method employs a dense, elastomeric array of sub-nanoliter wells (~100,000 wells/array) to spatially confine the T cells and target cells at defined ratios and is coupled to fluorescence microscopy to monitor effector-target conjugation and subsequent apoptosis.

Quantitativa High-throughput cella singola test di citotossicità per le cellule T

Cancer immunotherapy can harness the specificity of  immune response to target and eliminate tumors. Adoptive cell therapy (ACT)  based on the adoptive ...

Automated Quantification of Synaptic Fluorescence in C. elegans

Synapse strength refers to the amplitude of postsynaptic responses to presynaptic neurotransmitter release events, and has a major impact on overall neural circuit function. Synapse strength critically depends on the abundance of neurotransmitter receptors clustered at synaptic sites on the postsynaptic membrane. Receptor levels are established developmentally, and can be altered by receptor trafficking between surface-localized, subsynaptic, and intracellular pools, representing important mechanisms of synaptic plasticity and neuromodulation. Rigorous methods to quantify synaptically-localized neurotransmitter receptor abundance are essential to study synaptic development and plasticity. Fluorescence microscopy is an optimal approach because it preserves spatial information, distinguishing synaptic from non-synaptic pools, and discriminating among receptor populations localized to different types of synapses. The genetic model organism Caenorhabditis elegans is particularly well suited for these studies due to the small size and relative simplicity of its nervous system, its transparency, and the availability of powerful genetic techniques, allowing examination of native synapses in intact animals.
Here we present a method for quantifying fluorescently-labeled synaptic neurotransmitter receptors in C. elegans. Its key feature is the automated identification and analysis of individual synapses in three dimensions in multi-plane confocal microscope output files, tabulating position, volume, fluorescence intensity, and total fluorescence for each synapse. This approach has two principal advantages over manual analysis of z-plane projections of confocal data. First, because every plane of the confocal data set is included, no data are lost through z-plane projection, typically based on pixel intensity averages or maxima. Second, identification of synapses is automated, but can be inspected by the experimenter as the data analysis proceeds, allowing fast and accurate extraction of data from large numbers of synapses. Hundreds to thousands of synapses per sample can easily be obtained, producing large data sets to maximize statistical power. Considerations for preparing C. elegans for analysis, and performing confocal imaging to minimize variability between animals within treatment groups are also discussed. Although developed to analyze C. elegans postsynaptic receptors, this method is generally useful for any type of synaptically-localized protein, or indeed, any fluorescence signal that is localized to discrete clusters, puncta, or organelles.
The procedure is performed in three steps: 1) preparation of samples, 2) confocal imaging, and 3) image analysis. Steps 1 and 2 are specific to C. elegans, while step 3 is generally applicable to any punctate fluorescence signal in confocal micrographs.

Automated Quantification of Synaptic Fluorescence in C. elegans

The abundance of neurotransmitter receptors clustered at synapses strongly influences synaptic strength. This method quantifies fluorescently-labeled neurotransmitter receptors in three dimensions with single-synapse resolution in C. elegans, allowing hundreds of synapses to be rapidly characterized within a single sample without distortions introduced by z-plane projection.

Quantificazione automatica di fluorescenza in Synaptic<em&gt; C. elegans</em

Synapse strength refers to the amplitude of postsynaptic responses to presynaptic neurotransmitter release events, and has a major impact on overall ...

Neuroscienze

Antibody Profiling by Luciferase Immunoprecipitation Systems (LIPS)

Technologies for comprehensively understanding and quantifying antibody profiles to autoantigens and infectious agents may yield new insights into disease mechanisms and may elucidate new markers to substratify disease with different clinical features and better understand pathogenesis. We have developed a highly quantitative method called Luciferase Immunoprecipitation Systems (LIPS) for profiling patient sera antibody responses to autoantigens and pathogen antigens associated with infection. Unlike ELISAs, the highly sensitive LIPS is easily implemented to survey humoral serological response profiles to different antigens in a universal format and produces dynamic antibody titer ranges up to 6 log10 for some antigens. In these studies, quantitative profiling by LIPS of patient humoral responses against panels of antigens or even the entire proteome of some pathogens (i.e. HIV), is typically more informative than testing a single antigen by ELISA. In addition, LIPS also eliminates time and effort needed to produce highly purified antigens as well as the labor-intensive assay optimization steps needed for standard ELISAs. Here we provide a detailed protocol describing the technical aspects of performing LIPS assays for readily profiling antibody responses to single or multiple antigens.

Antibody Profiling by Luciferase Immunoprecipitation Systems LIPS

The technical aspects of performing LIPS (Luciferase Immunoprecipitation Systems) are described. The overall approach involves expressing chimeric genes encoding antigens fused to Renilla luciferase (Ruc) in mammalian cells. Crude Ruc-antigen extracts are then prepared and, without purification, employed in immunoprecipitation assays to quantify antibodies.

Profiling anticorpi Systems Immunoprecipitazione luciferasi (LIPS)

Technologies for comprehensively understanding and quantifying antibody profiles to autoantigens and infectious agents may yield new insights into disease ...

Biologia

Western Blotting: Sample Preparation to Detection

Western blotting is an analytical technique used to detect specific proteins in a given sample of tissue homogenate or extract. It uses gel electrophoresis to separate native or denatured proteins by the length of the polypeptide (denaturing conditions) or by the 3-D structure of the protein (native/ non-denaturing conditions). The proteins are then transferred to a membrane (typically nitrocellulose or PVDF), where they are probed (detected) using antibodies specific to the target protein.

Western blotting is an analytical technique used to detect specific proteins in a given sample of tissue homogenate or extract.

Western Blotting: la preparazione dei campioni di rilevamento

Western blotting is an analytical technique used to detect specific proteins in a given sample of tissue homogenate or extract. It uses gel ...

Mutagenesis and Analysis of Genetic Mutations in the GC-rich KISS1 Receptor Sequence Identified in Humans with Reproductive Disorders

The kisspeptin receptor (KISS1R) is a G protein-coupled receptor recognized as the trigger of puberty and a regulator of reproductive competence in adulthood 1,2,3. Inactivating mutations in KISS1R identified in patients have been associated with iodiopathic hypogonadotropic hypogonadism (IHH) 1,2 and precocious puberty 4. Functional studies of these mutants are crucial for our understanding of the mechanisms underlying the regulation of reproduction by this receptor as well as those shaping the disease outcomes, which result from abnormal KISS1R signaling and function. However, the highly GC-rich sequence of the KISS1R gene makes it rather difficult to introduce mutations or amplify the gene encoding this receptor by PCR.
Here we describe a method to introduce mutations of interest into this highly GC-rich sequence that has been used successfully to generate over a dozen KISS1R mutants in our laboratory. We have optimized the PCR conditions to facilitate the amplification of a range of KISS1R mutants that include substitutions, deletions or insertions in the KISS1R sequence. The addition of a PCR enhancer solution, as well as of a small percentage of DMSO were especially helpful to improve amplification. This optimized procedure may be useful for other GC-rich templates as well.
The expression vector encoding the KISS1R is been used to characterize signaling and function of this receptor in order to understand how mutations may change KISS1R function and lead to the associated reproductive phenotypes. Accordingly, potential applications of KISS1R mutants generated by site-directed mutagenesis can be illustrated by many studies 1,4,5,6,7,8. As an example, the gain-of-function mutation in the KISS1R (Arg386Pro), which is associated with precocious puberty, has been shown to prolong responsiveness of the receptor to ligand stimulation 4 as well as to alter the rate of degradation of KISS1R 9. Interestingly, our studies indicate that KISS1R is degraded by the proteasome, as opposed to the classic lysosomal degradation described for most G protein-coupled receptors 9. In the example presented here, degradation of the KISS1R is investigated in Human Embryonic Kidney Cells (HEK-293) transiently expressing Myc-tagged KISS1R (MycKISS1R) and treated with proteasome or lysosome inhibitors. Cell lysates are immunoprecipitated using an agarose-conjugated anti-myc antibody followed by western blot analysis. Detection and quantification of MycKISS1R on blots is performed using the LI-COR Odyssey Infrared System. This approach may be useful in the study of the degradation of other proteins of interest as well.

Mutations in the kisspeptin receptor (KISS1R) are associated with reproductive disorders in patients. Here we describe how to introduce mutations of interest in the GC-rich sequence of KISS1R as well as the use of KISS1R constructs to characterize the degradation pathway of the receptor by immunoprecipitation and western blot.

Mutagenesi e analisi delle mutazioni genetiche in GC-ricchi Sequenza Receptor KISS1 identificati nell&#39;uomo con disturbi dell&#39;apparato riproduttivo

The kisspeptin receptor (KISS1R) is a G protein-coupled receptor recognized as the trigger of puberty and a regulator of reproductive competence in ...

Monitoring Kinase and Phosphatase Activities Through the Cell Cycle by Ratiometric FRET

F&ouml;rster resonance energy transfer (FRET)-based reporters1 allow the assessment of endogenous kinase and phosphatase activities in living cells. Such probes typically consist of variants of CFP and YFP, intervened by a phosphorylatable sequence and a phospho-binding domain. Upon phosphorylation, the probe changes conformation, which results in a change of the distance or orientation between CFP and YFP, leading to a change in FRET efficiency (Fig 1). Several probes have been published during the last decade, monitoring the activity balance of multiple kinases and phosphatases, including reporters of PKA2, PKB3, PKC4, PKD5, ERK6, JNK7, Cdk18, Aurora B9 and Plk19. Given the modular design, additional probes are likely to emerge in the near future10. 
Progression through the cell cycle is affected by stress signaling pathways 11. Notably, the cell cycle is regulated differently during unperturbed growth compared to when cells are recovering from stress12.Time-lapse imaging of cells through the cell cycle therefore requires particular caution. This becomes a problem particularly when employing ratiometric imaging, since two images with a high signal to noise ratio are required to correctly interpret the results. Ratiometric FRET imaging of cell cycle dependent changes in kinase and phosphatase activities has predominately been restricted to sub-sections of the cell cycle8,9,13,14.
Here, we discuss a method to monitor FRET-based probes using ratiometric imaging throughout the human cell cycle. The method relies on equipment that is available to many researchers in life sciences and does not require expert knowledge of microscopy or image processing.

FRET-based reporters are increasingly used to monitor kinase and phosphatase activities in live cells. Here we describe a method on how to use FRET-based reporters to assess cell cycle-dependent changes in target phosphorylation.

Monitoraggio Attività chinasi e fosfatasi attraverso il ciclo cellulare da raziometrica FRET

F&ouml;rster resonance energy transfer (FRET)-based reporters1 allow the assessment of endogenous kinase and phosphatase activities in living cells. Such ...

Assaying the Kinase Activity of LRRK2 in vitro

Leucine Rich Repeat Kinase 2 (LRRK2) is a 2527 amino acid member of the ROCO family of proteins, possessing a complex, multidomain structure including a GTPase domain (termed ROC, for Ras of Complex proteins) and a kinase domain1. The discovery in 2004 of mutations in LRRK2 that cause Parkinson's disease (PD) resulted in LRRK2 being the focus of a huge volume of research into its normal function and how the protein goes awry in the disease state2,3. Initial investigations into the function of LRRK2 focused on its enzymatic activities4-6. Although a clear picture has yet to emerge of a consistent alteration in these due to mutations, data from a number of groups has highlighted the importance of the kinase activity of LRRK2 in cell death linked to mutations7,8. Recent publications have reported inhibitors targeting the kinase activity of LRRK2, providing a key experimental tool9-11. In light of these data, it is likely that the enzymatic properties of LRRK2 afford us an important window into the biology of this protein, although whether they are potential drug targets for Parkinson's is open to debate.
A number of different approaches have been used to assay the kinase activity of LRRK2. Initially, assays were carried out using epitope tagged protein overexpressed in mammalian cell lines and immunoprecipitated, with the assays carried out using this protein immobilised on agarose beads4,5,7. Subsequently, purified recombinant fragments of LRRK2 in solution have also been used, for example a GST tagged fragment purified from insect cells containing residues 970 to 2527 of LRRK212. Recently, Dani&euml;ls et al. reported the isolation of full length LRRK2 in solution from human embryonic kidney cells, however this protein is not widely available13. In contrast, the GST fusion truncated form of LRRK2 is commercially available (from Invitrogen, see table 1 for details), and provides a convenient tool for demonstrating an assay for LRRK2 kinase activity. Several different outputs for LRRK2 kinase activity have been reported. Autophosphorylation of LRRK2 itself, phosphorylation of Myelin Basic Protein (MBP) as a generic kinase substrate and phosphorylation of an artificial substrate - dubbed LRRKtide, based upon phosphorylation of threonine 558 in Moesin - have all been used, as have a series of putative physiological substrates including &alpha;-synuclein, Moesin and 4-EBP14-17. The status of these proteins as substrates for LRRK2 remains unclear, and as such the protocol described below will focus on using MBP as a generic substrate, noting the utility of this system to assay LRRK2 kinase activity directed against a range of potential substrates.

Assaying the Kinase Activity of LRRK2 in vitro

Leucine Rich Repeat Kinase 2 is a large multidomain kinase, mutations in which are the most common genetic cause of Parkinson's disease. Analysis of the kinase activity of this protein has proven to be a crucial tool in understanding the biology and dysfunction of this protein. In this paper, in vitro assaying of the kinase activity of LRRK2 and a selection of its mutants is described, providing an experimental system to examine phosphorylation of putative substrates and potential dysfunction of LRRK2 in disease.

Saggiare l&#39;attività chinasi di LRRK2 In vitro</em

Leucine Rich Repeat Kinase 2 (LRRK2) is a 2527 amino acid member of the ROCO family of proteins, possessing a complex, multidomain structure including a ...

Design and Use of Multiplexed Chemostat Arrays

Chemostats are continuous culture systems in which cells are grown in a tightly controlled, chemically constant environment where culture density is constrained by limiting specific nutrients.1,2 Data from chemostats are highly reproducible for the measurement of quantitative phenotypes as they provide a constant growth rate and environment at steady state. For these reasons, chemostats have become useful tools for fine-scale characterization of physiology through analysis of gene expression3-6 and other characteristics of cultures at steady-state equilibrium.7 Long-term experiments in chemostats can highlight specific trajectories that microbial populations adopt during adaptive evolution in a controlled environment. In fact, chemostats have been used for experimental evolution since their invention.8 A common result in evolution experiments is for each biological replicate to acquire a unique repertoire of mutations.9-13 This diversity suggests that there is much left to be discovered by performing evolution experiments with far greater throughput. 
We present here the design and operation of a relatively simple, low cost array of miniature chemostats&mdash;or ministats&mdash;and validate their use in determination of physiology and in evolution experiments with yeast. This approach entails growth of tens of chemostats run off a single multiplexed peristaltic pump. The cultures are maintained at a 20 ml working volume, which is practical for a variety of applications. It is our hope that increasing throughput, decreasing expense, and providing detailed building and operation instructions may also motivate research and industrial application of this design as a general platform for functionally characterizing large numbers of strains, species, and growth parameters, as well as genetic or drug libraries.

We developed and validated a small-footprint array of miniature chemostats built from readily available parts for low cost. Physiological and experimental evolution results were similar to larger volume chemostats. The ministat array provides a compact, inexpensive, and accessible platform for traditional chemostat experiments, functional genomics, and chemical screening applications.

Progettazione e utilizzo di matrici chemostato multiplexing

Chemostats are continuous culture systems in which cells are grown in a tightly controlled, chemically constant environment where culture density is ...